Scientific overview
This research blend combines a GHRH-analog peptide cataloged as CJC-1295 without DAC with ipamorelin, a growth-hormone secretagogue. The two components are associated with distinct receptor pathways relevant to endocrine-signaling research. The no-DAC designation differentiates this formulation from the albumin-binding DAC form; results from DAC studies should not be assumed to apply to this product.
Specifications
| Product | CJC1295 5mg IPA 5mg no Dac |
|---|---|
| Vial content | 10 mg total |
| Form | Lyophilized powder |
| Research focus | GHRH and growth-hormone secretagogue receptor pathways |
| Composition | CJC-1295 without DAC 5 mg · Ipamorelin 5 mg |
Documentation
Certificate of Analysis (COA): In process. Batch-specific documentation will be added when available.
Research use only
For laboratory research and analytical use only. Not for human or veterinary use, consumption, or administration. This material is not a medicine and is not offered to diagnose, treat, cure, or prevent disease.
Reviews
There are no reviews yet.